LIFE
Lawsuits in U.S. demand unproven ivermectin for COVID-19 patients
ByKaren Graham
PublishedOctober 17, 2021
The FDA has received multiple reports of patients who have required medical attention, including hospitalization, after self-medicating with ivermectin intended for livestock. Source - U.S. Food and Drug Administration, Public Domain
There have been at least two dozen lawsuits filed around the U.S. demanding hospitals give ivermectin, a deworming drug, to COVID-19 patients.
CBC Canada is reporting that considerable interest in the drug occurred earlier this year after a few studies, many of them withdrawn in other countries, seemed to suggest ivermectin had some potential and it became a hot topic of conversation among conservatives on social media.
During the COVID-19 pandemic, ivermectin dispensing by retail pharmacies has increased, as has the use of veterinary formulations available over the counter but not intended for human use. FDA has cautioned about the potential risks of use for prevention or treatment of COVID-19.
While the drug was approved by the FDA to treat tiny parasites in people, the administration, state health departments, and even the drug’s leading manufacturer, Merck, have all warned against using it for COVID-19. 
The lawsuits all seem to follow the same format; families have gotten a prescription for the drug, but hospitals refuse to use it on the patients, many of whom are on a ventilator, close to death, The Hill reports.
The Associated Press noted that most of the lawsuits are filed by Ralph Lorigo, an attorney in Buffalo, N.Y. who says doctors “are not gods because they wear white jackets,” adding that he takes issue with the choice not to use ivermectin on patients.
So far, the lawsuits have created a mix of court decisions, with some judges refusing to order a hospital to give the unproven drug to a patient, while others have ordered medical providers to give the medication, despite concerns it could be harmful.
In a September case on Staten Island, state Supreme Court Judge Ralph Porzio refused to order the use of ivermectin in a situation where a man sued a hospital on behalf of his ill father, citing its unproven impact.
“This court will not require any doctor to be placed in a potentially unethical position wherein they could be committing medical malpractice by administering a medication for an unapproved, alleged off-label purpose,” he wrote.
In this article:
deworming drug
,
Ivermectin
,
Lawsuits
,
Treatment of Covid-19
,
unproven studies
WRITTEN BY
Karen Graham
Karen Graham is Digital Journal's Editor-at-Large for environmental news. Karen's view of what is happening in our world is colored by her love of history and how the past influences events taking place today. Her belief in man's part in the care of the planet and our environment has led her to focus on the need for action in dealing with climate change. It was said by Geoffrey C. Ward, "Journalism is merely history's first draft." Everyone who writes about what is happening today is indeed, writing a small part of our history.
ADVERTISEMENT
TRENDING
Canada confirms its first two cases of the Omicron variant
Hanukkah, the Jewish ‘Festival of Lights’ begins tonight
US bids farewell to Trump hotel that offered luxury… and access
A lake that was drained a century ago in British Columbia has filled again
Artificial intelligence reveals the secrets of the spider web
You may also like:
Five cybersecurity myths that need to be busted
Op-Ed: Supreme Court vs US Constitution and Roe vs Wade – No winners, ever
Christmas trees are in short supply this holiday season
What we know about the Omicron coronavirus variant so far
ABOUT US
SPONSORED CONTENT
TERMS OF USE
PRIVACY POLICY
CONTACT US
NEWS PARTNER: AFP
NEWS PARTNER: DX JOURNAL
ALL PRESS RELEASES
FEATURED: ACCESSWIRE
FEATURED: PRODIGY PRESS WIRE
FEATURED: RELEASEWIRE
FEATURED: XHERALD
FEATURED: 11PRESS
COPYRIGHT © 1998 - 2021 DIGITAL JOURNAL INC. Digital Journal is not responsible for the content of external sites. Read more about our external linking.
WORLDTECH & SCIENCESOCIAL MEDIABUSINESSENTERTAINMENTLIFESPORTS